ClinicalTrials.gg
RecruitingNCT07458152Updated Nov 4, 2026

Comparison of Wrist Splint Positions in Carpal Tunnel Syndrome

An interventional study of Flexion Splint and Neutral Splint in Carpal Tunnel Syndrome (CTS), Peripheral Neuropathies and Median Nerve Entrapment, sponsored by Istanbul University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Istanbul University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.
Updated Nov 4, 2026Now RecruitingFirst site in Turkey (Türkiye)+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
108
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 130 studies in Carpal Tunnel Syndrome with a site in Turkey — 36 open to participants now, 41 under way, none of them phase 3. Carpal Tunnel Syndrome · Turkey.

Planned enrollment
3rd of 82
108 · median 60
Started
2026
with 19 others
No phase
75 of 130
21 open now
Primary completion
2029-01
later than 40 of 40 live
Registered
114th of 130
by date
Lead sponsor
7 of 130
Istanbul University

Among the 130 studies in Carpal Tunnel Syndrome with a site in Turkey, this one is the 3rd largest by planned enrollment of the 82 interventional ones that give a count, is one of 20 that started in 2026, is one of 75 with no phase, reaches primary completion later than 40 of the 40 other live ones, and was the 114th registered.

Carpal Tunnel Syndrome

591 studies on the registry are indexed under Carpal Tunnel Syndrome; 133 are open to participants now.

Browse Carpal Tunnel Syndrome studies →

Open to participants now

36 of the 130 studies in Carpal Tunnel Syndrome with a site in Turkey are open now. Recruiting first, the newest first:

30 more — sign in →

All 36 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 72 Carpal Tunnel Syndrome studies recruiting now, 27 (38%) set no upper age limit and 36 (50%) stop at 75 or younger; 1 takes children under 18; 11 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 130 studies in Carpal Tunnel Syndrome with a site in Turkey, or all of them as a file.
02

Study summary

Carpal tunnel syndrome (CTS) is the most common nerve compression syndrome. It develops as a result of the compression of the median nerve while passing through the osteofibrous structure of the carpal tunnel located at the wrist. Sensory symptoms are the most prominent feature of CTS. These symptoms are observed as pain, paresthesia, and decreased sensory sensitivity. As motor symptoms, thumb abduction and opposition are primarily affected. In advanced cases, atrophy develops in the thenar muscles. Patients may describe weakness as difficulty in writing, opening jars, buttoning, or grasping objects. The diagnosis is made by fulfilling both clinical and electrophysiological diagnostic criteria. CTS has both conservative and surgical treatment options. Conservative treatment includes splinting, physical therapy modalities, and injection options, and it is preferred in mild and moderate cases. Among non-surgical treatment options, splint use is a commonly applied intervention; however, there is no consensus regarding its effectiveness, the optimal wrist position during use, or the duration and frequency of splint application. A total of 108 hands from patients aged 18 to 55 years diagnosed with CTS will be included in this study and randomized into three groups. All groups will be given an education and exercise program. The first group will use a wrist splint fixed at 15° flexion; the second group at neutral position; and the third group at 20° extension, to be worn only at night for eight weeks. Patients will be evaluated before treatment, immediately after treatment, and two months after the end of treatment using measures of pain- numbness severity, functional status, motor and sensory examination findings, and nerve conduction studies. What makes this study unique is that it evaluates the effects of splints that stabilize the wrist at different angles together with electrophysiological findings. A review of the literature shows that while some studies have examined and compared the effects of splints fixed at different wrist angles on symptoms, functional status, and physical examination findings, there is no study that evaluates these effects along with electrophysiological findings. Therefore, this study, which will compare the effectiveness of splints at different angles, is expected to contribute to the literature. The expected outcomes of this research are that one or more types of splints used in the conservative treatment of CTS will provide improvements in symptom severity, functional status, sensory and motor physical examination findings, and electrophysiological evaluation findings at the end of treatment.

03

Conditions studied

  • Carpal Tunnel Syndrome (CTS)
  • Peripheral Neuropathies
  • Median Nerve Entrapment

Keywords

  • Splints
  • Electromyography
  • Wrist splinting
  • Rehabilitation
  • Wrist posture
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of mild to moderate carpal tunnel syndrome confirmed by electrophysiological studies performed within the last year.
  • Clinical findings consistent with carpal tunnel syndrome.
  • Age between 18 and 65 years.

Exclusion criteria

Exclusion Criteria:

  • \<18 years or >65 years
  • Thenar atrophy
  • Surgery history for CTS
  • injection for CTS
  • Physical treatment for CTS in the last 6 months
  • Cervical radiculopathy
  • Tenosynovitis
  • Peripheral polyneuropathy
  • Another compressive neuropathy in the ipsilateral upper extremity
  • History of trauma/fracture to the hand-wrist region
  • Pregnancy
  • Metabolic disease
  • Rheumatic/ disease
  • Kidney failure
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
108 participants (estimated)

Study arms

  • Active comparator
    15° Flexion Wrist Splint Group

    Other: Flexion Splint · Behavioral: Education · Other: Exercise

  • Active comparator
    Neutral Wrist Splint Group

    Other: Neutral Splint · Behavioral: Education · Other: Exercise

  • Active comparator
    20° Extension Wrist Splint Group

    Other: Extension Splint · Behavioral: Education · Other: Exercise

Interventions

  • OtherFlexion Splint

    Participants will wear wrist splint fixed at 15° of wrist flexion during nighttime only for eight weeks.

  • OtherNeutral Splint

    Participants will wear a wrist splint maintaining the wrist in a neutral position during nighttime only for eight weeks.

  • OtherExtension Splint

    Participants will wear a wrist splint fixed at 20° of wrist extension during nighttime only for eight weeks.

  • BehavioralEducation

    All participants will also receive a standardized education.

  • OtherExercise

    All participants will also receive a standardized exercise program.

06

What researchers measure

Primary outcomes

  1. Nerve Conduction Study (NCS)

    Median motor distal latency and conduction velocity and second finger recorded median sensory distal latency and conduction velocity will be measured in all individuals. In addition to routine conduction examinations, fourth finger recorded median-ulnar peak latency comparison examinations will also be made.

    Time frame: Baseline and week 12 (follow-up)

Secondary outcomes

  1. Visual Pain Scale (VAS)

    Pain and numbness at rest, at night, and during movement will be assessed using a visual analog scale (VAS) ranging from 0 to 10, where 0 represents "no pain" and 10 represents "unbearable pain."

    Time frame: Baseline, Week 8 (end of intervention) and Week 12 (follow-up)

  2. Boston Carpal Tunnel Syndrome Questionnaire (BCTSQ)

    BCTSQ assesses the severity of symptoms and functional status in patients with carpal tunnel syndrome. The symptom severity scale assesses the symptoms with respect to severity, frequency, time and type. The scale consists of 11 questions with multiple-choice responses, scored from 1 point (mildest) to 5 points (most severe). The overall symptom severity score is calculated as the mean of the scores for the eleven individual items. The functional status scale assesses the affect of the carpal tunnel syndrome on daily living. The scale consists of 8 questions with multiple choice responses, scored from 1 point (no difficulty with the activity) to 5 points (can not perform the activity at all). The overall score for functional status was calculated as the mean of all eight. Thus, a higher symptom severity or functional status score indicates worse symptoms or dysfunction.

    Time frame: Baseline, Week 8 (end of intervention) and Week 12 (follow-up)

  3. Semmes Weinstein Monofilament Test (SWMT)

    Using 20 pieces of SWMT, sensitive touch threshold sensitivity of each hand will be tested. The examiner and the subject will seated opposite each other. Both arms of the subject will arranged on a table in supination, with palm upwards. The patient will be instructed to close their eyes. The monofilaments will be touched fingertips of first three fingers on the radial side of both hands, with enough force to bend the monofilament for 1.5 seconds. The thinnest monofilament numbers that the patient feels being touched will be recorded.

    Time frame: Baseline, Week 8 (end of intervention) and Week 12 (follow-up)

  4. Two Point Discrimination Test (TPDT)

    Two point discrimination sense will be evaluated statically using an esthesiometer. The examiner and the subject will seated opposite each other. Both arms of the subject will arranged on a table in supination, with palm upwards. The patient will be instructed to close their eyes. The contact time of the discriminator with the fingertip ranged from 3 to 5 seconds. The evaluation will be started by touching a single point on the first three fingertips on the radial side of both hands. Each three fingers will be evaluated separately and the distance between the two touched points will be increased by 1mm in each measurement. The smallest values will be taken in millimeters which the patient feels the two points as two separate points on the tested hand will be noted and the the average value written as the result.

    Time frame: Baseline, Week 8 (end of intervention) and Week 12 (follow-up)

  5. Hand Grip Force

    The squeeze force will be measured while the patients are sitting, with the elbow in 90 degrees flexion and they will be asked to make a maximally voluntary grip. Measurements will be made three times in a row on both hands and the average of the three measurements will be noted as a result in kilogram (kg).

    Time frame: Baseline, Week 8 (end of intervention) and Week 12 (follow-up)

  6. Thumb and Forefinger Pinch Force

    The pinch force with thumb and forefinger will be measured while the patients are sitting, with the elbow in 90 degrees flexion and they will be asked to make a maximally voluntary grip.The pinch force will be measured as kg with a pinch dynamometer, and the average of the three measurements will be noted as a result.

    Time frame: Baseline, Week 8 (end of intervention) and Week 12 (follow-up)

  7. Manuel Muscle Testing of M. Abductor Pollicis Brevis

    Manual muscle testing will be evaluated in 5 grades. No visible or palpable muscle contraction 0, visible or palpable muscle contraction without motion grade 1, muscle contraction that creates movement at full of range of motion when gravity is eliminated grade 2, muscle contraction that creates movement at full of range of motion against gravity grade 3, muscle contraction that creates movement at full of range of motion against gravity and moderate resistance grade 4, muscle contraction that creates movement through the entire range of motion of the joint against gravity and full resistance will be considered as the grade 5

    Time frame: Baseline, Week 8 (end of intervention) and Week 12 (follow-up)

  8. Vibration Sensation

    Vibration sense was tested with tuning fork. The examiner and the subject will be seated opposite each other. Both arms of the subject will be arranged on a table in supination, with palm upwards. The patient will be instructed to close their eyes. Vibrating tuning fork will be placed on the palmar aspect of the distal phalanx of first three fingers on the radial side of both hands, The patient will be asked to say 'done' when the vibration in his hand was over. The average of three measurements will be noted as a result in seconds.

    Time frame: Baseline, Week 8 (end of intervention) and Week 12 (follow-up)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Jan 2029, 34 months after the start.

Of 252 non-industry interventional studies with no phase under Carpal Tunnel Syndrome, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 27. This study's planned 34 months is above that.

Counting every sponsor, half of 262 studies reached it within 12 months; a quarter within 7 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 3, 2026
First posted
Mar 9, 2026
StartActual
Mar 1, 2026
Primary completionEst.
Jan 2029
CompletionEst.
Jan 2029
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 4, 2026
Sites
1 site added — first site in Turkey (Türkiye)
Show site
  • Istanbul University · Istanbul, Turkey (Türkiye)
Nov 4, 2026
Primary outcomes
1 time frame changed
What changed in the outcomes
  • Time frameNerve Conduction Study (NCS)Baseline and sixteen week of intervention → Baseline and week 12 (follow-up)
Nov 4, 2026
Secondary outcomes
8 time frame changed
What changed in the outcomes
  • Time frameVisual Pain Scale (VAS)Baseline, eight week of intervention, sixteen week of intervention → Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
  • Time frameBoston Carpal Tunnel Syndrome Questionnaire (BCTSQ)Baseline, eight week of intervention, sixteen week of intervention → Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
  • Time frameSemmes Weinstein Monofilament Test (SWMT)Baseline, eight week of intervention, sixteen week of intervention → Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
  • Time frameTwo Point Discrimination Test (TPDT)Baseline, eight week of intervention, sixteen week of intervention → Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
  • Time frameHand Grip ForceBaseline, eight week of intervention, sixteen week of intervention → Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
  • Time frameThumb and Forefinger Pinch ForceBaseline, eight week of intervention, sixteen week of intervention → Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
  • Time frameManuel Muscle Testing of M. Abductor Pollicis BrevisBaseline, eight week of intervention, sixteen week of intervention → Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
  • Time frameVibration SensationBaseline, eight week of intervention, sixteen week of intervention → Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Turkey (Türkiye)
    Show site
    • Istanbul University · Istanbul, Turkey (Türkiye)
    Primary outcomes 1 time frame changed
    What changed in the outcomes
    • Time frameNerve Conduction Study (NCS)Baseline and sixteen week of intervention → Baseline and week 12 (follow-up)
    Secondary outcomes 8 time frame changed
    What changed in the outcomes
    • Time frameVisual Pain Scale (VAS)Baseline, eight week of intervention, sixteen week of intervention → Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
    • Time frameBoston Carpal Tunnel Syndrome Questionnaire (BCTSQ)Baseline, eight week of intervention, sixteen week of intervention → Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
    • Time frameSemmes Weinstein Monofilament Test (SWMT)Baseline, eight week of intervention, sixteen week of intervention → Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
    • Time frameTwo Point Discrimination Test (TPDT)Baseline, eight week of intervention, sixteen week of intervention → Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
    • Time frameHand Grip ForceBaseline, eight week of intervention, sixteen week of intervention → Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
    • Time frameThumb and Forefinger Pinch ForceBaseline, eight week of intervention, sixteen week of intervention → Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
    • Time frameManuel Muscle Testing of M. Abductor Pollicis BrevisBaseline, eight week of intervention, sixteen week of intervention → Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
    • Time frameVibration SensationBaseline, eight week of intervention, sixteen week of intervention → Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
    + 1 other change: date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07458152
Responsible party
Fatma Merih Akpınar (Assistant Professor, Istanbul University) — Principal investigator
First posted
Mar 9, 2026
Start date
Mar 1, 2026
Primary completion
Jan 2029 (estimated)
Completion
Jan 2029 (estimated)
Last update
Nov 4, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion